S510-0311 Screening compound: 2-{5-[3-(4-methylpiperazin-1-yl)-3-oxopropyl]-1,2,4-oxadiazol-3-yl}-N-(propan-2-yl)pyrrolidine-1-carboxamide

S510-0311 Screening compound: 2-{5-[3-(4-methylpiperazin-1-yl)-3-oxopropyl]-1,2,4-oxadiazol-3-yl}-N-(propan-2-yl)pyrrolidine-1-carboxamide
S510-0311 Screening compound: 2-{5-[3-(4-methylpiperazin-1-yl)-3-oxopropyl]-1,2,4-oxadiazol-3-yl}-N-(propan-2-yl)pyrrolidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S510-0311
2-{5-[3-(4-methylpiperazin-1-yl)-3-oxopropyl]-1,2,4-oxadiazol-3-yl}-N-(propan-2-yl)pyrrolidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S510-0311

Molecular Formula

C18H30N6O3 (C18 H30 N6 O3)

Compound Name

2-{5-[3-(4-methylpiperazin-1-yl)-3-oxopropyl]-1,2,4-oxadiazol-3-yl}-N-(propan-2-yl)pyrrolidine-1-carboxamide

IUPAC name

2-{5-[3-(4-methylpiperazin-1-yl)-3-oxopropyl]-124-oxadiazol-3-yl}-N-(propan-2-yl)pyrrolidine-1-carboxamide

SMILES

CC(C)NC(N(CCC1)C1c1noc(CCC(N2CCN(C)CC2)=O)n1)=O

InChI

InChI=1S/C18H30N6O3/c1-13(2)19-18(26)24-8-4-5-14(24)17-20-15(27-21-17)6-7-16(25)23-11-9-22(3)10-12-23/h13-14H,4-12H2,1-3H3,(H,19,26)/t14-/m0/s1

InChI Key

JBNLNUPBVACERP-AWEZNQCLSA-N

MDL Number (MFCD)

MFCD31978780

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

378.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.517

Distribution Coefficient, logD

0.270

Water Solubility, LogSw

-1.15

Polar Surface Area

77.276

Acid Dissociation Constant (pKa)

17.19

Base Dissociation Constant (pKb)

7.28

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

77.78

S510-0311 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS MPO Library (28609 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S510-0311 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S510-0311?
Check Price and Availability of S510-0311, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S510-0311 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S510-0311
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S510-0311
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S510-0311 available by request